Exact Science Prices Public Offering At $9.75 Per Share

EXACT Sciences Q1 13 Earnings Conference Call At 10:00 AM ET

Exact Sciences: Cologuard Colorectal Cancer Screening Test Met Primary Endpoints

In The Spotlight: Exact Sciences Corp

EXACT Sciences To Present At Citi Healthcare Conference; Webcast At 11:05 AM ET

Trade EXAS now with

8/8/2012 9:51 AM ET

Exact Sciences Corp. (EXAS: Quote), announced Wednesday an underwritten public offering of 5,500,000 shares at a price of $9.75 per share.

After deducting underwriting discounts and commissions and other estimated offering expenses, net proceeds are expected to be $50.2 million.

Underwriters are given a 30-day option to purchase up to 825,000 shares of stocks.

The offering may close on or before August 13, 2012, subject to customary closing conditions.

Jefferies & Company, Inc. and Robert W. Baird & Co. Inc., are acting as joint book managers. Meanwhile, William Blair & Company, L.L.C. and JMP Securities LLC are acting as co-managers for the offering.

Click here to receive FREE breaking news email alerts for EXACT Sciences Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

More Breaking News

<<Previous 73 Articles

Editors Pick

China Manufacturing Contracts As New Orders Slump

China's manufacturing sector contracted for the first time in seven months in May amid poor demand, fueling concerns that the weakness in the economy may persist for some more time. The headline purchasing managers' index, an indicator of the health of the factory sector, fell to a seven-month low of 49.6 in May from 50.4 in April. Readings below 50 indicate contraction of the sector.

HP Profit Falls Yet Tops Estimates

Hewlett-Packard Co. said Wednesday after the markets closed that its second quarter profit fell 32% from last year, hurt by lower revenue and weaker margins amid a slump in PC sales. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations, but its quarterly revenue fell short of analysts' forecast.

Worries About Fed Tapering Lead To Sell-Off On Wall Street - U.S. Commentary

Stocks showed a substantial downturn over the course of the trading day on Wednesday after seeing some strength in morning trading. Renewed worries about the Federal Reserve tapering its asset purchase program contributed to the sharp pullback by the markets. The major averages climbed off their worst levels going into the close but still ended the day firmly negative.